Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: AtriCure, Inc.

Market Cap 1.46B 1.26B 1.16B 1.09B 2.04B 139B 2.07B 13.7B 5.34B 67.45B 5.47B 5.36B 234B P/E Ratio 2026 *
628x
P/E Ratio 2027 * 84.7x
Enterprise Value 1.3B 1.12B 1.04B 970M 1.82B 124B 1.85B 12.24B 4.77B 60.24B 4.89B 4.78B 209B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.81x
Free-Float
96.14%
Yield 2026 *
-
Yield 2027 * -
1 day+1.34%
1 week+6.24%
Current month+4.05%
1 month+2.27%
3 months-3.53%
6 months-32.07%
Current year-27.22%
1 week 26.84
Extreme 26.835
28.91
1 month 25.36
Extreme 25.36
29.45
Current year 25.36
Extreme 25.36
43.18
1 year 25.36
Extreme 25.36
43.18
3 years 18.94
Extreme 18.94
59.61
5 years 18.94
Extreme 18.94
89.18
10 years 13.45
Extreme 13.45
89.18
Manager TitleAgeSince
Chief Executive Officer 55 01/11/2012
Director of Finance/CFO 48 30/06/2014
Chief Tech/Sci/R&D Officer 59 17/07/2017
Director TitleAgeSince
Director/Board Member 55 01/11/2012
Director/Board Member 64 10/03/2013
Director/Board Member 75 09/11/2016
Date Insider Type Main position Quantity % Market Cap.
05-19Sell

Director

-3,000 0.0059%
05-17Free

Director

6,144 0.0121%
05-17Free

Director

6,144 0.0121%
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%+6.24%-8.95%-41.34% 1.46B
-1.64%-3.17%-34.98%-14.60% 154B
-0.16%-1.80%-8.10%-8.77% 103B
+0.76%+5.30%+61.53%+48.34% 55.22B
+0.07%+2.41%-4.69%+57.31% 54.8B
-0.75%-3.25%-15.08%-42.27% 40.3B
-1.40%+8.93% - - 30.96B
+0.16%+3.44%-8.07%-40.68% 29.08B
-0.46%+4.55%+48.18%-7.29% 23.23B
+3.34%-0.50%-12.46%-0.87% 20.25B
Average +0.13%+1.41%+1.93%-5.57% 51.19B
Weighted average by Cap. -0.45%-0.46%-6.35%-0.97%

Financials

2026 *2027 *
Net sales 605M 522M 481M 451M 845M 57.5B 858M 5.69B 2.22B 27.99B 2.27B 2.22B 96.91B 678M 586M 540M 505M 947M 64.49B 962M 6.38B 2.49B 31.39B 2.55B 2.49B 109B
Net income 2.66M 2.3M 2.12M 1.98M 3.71M 253M 3.77M 25M 9.75M 123M 9.98M 9.77M 426M 17.48M 15.1M 13.92M 13.03M 24.41M 1.66B 24.79M 164M 64.06M 809M 65.62M 64.22M 2.8B
Net Debt -156M -135M -124M -116M -218M -14.83B -221M -1.47B -572M -7.22B -585M -573M -24.99B -232M -201M -185M -173M -324M -22.08B -329M -2.18B -851M -10.75B -872M -853M -37.21B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
12/06/26 28.79 $ +1.34% 700,874
11/06/26 28.41 $ +3.27% 1,105,142
10/06/26 27.51 $ +0.77% 703,862
09/06/26 27.30 $ +1.43% 607,249
08/06/26 26.92 $ -0.68% 559,543
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
28.79USD
Average target price
47.00USD
Spread / Average Target
+63.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!